Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-25-004041

Chief Executive Officer sold 8,009 shares at $236.77 ($1,896,307)

  • Chief Executive Officer acquired 8,009 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Farrell Michael J. Chief Executive Officer 2025-02-07 Option exercise 10b5-1 +8,009 $101.64 $814,035 463,481 D: show line 1 in the form
Farrell Michael J. Chief Executive Officer 2025-02-07 Sale 10b5-1 −8,009 $236.77 $1,896,307 455,472 D: show line 2 in the form
Open-market sales · 8,009 sh · avg $236.77 · $1,896,307

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Farrell Michael J. Chief Executive Officer 2025-02-07 Option exercise · ResMed Common Stock Options 10b5-1 −8,009 72,083 D: show line 3 in the form
Loading xslF345X05/form4.xml…